THE QUANTUM LEAP FROM 3D TO 6D BIOPRINTING AND ITS IMPACT ON THE MANAGEMENT OF DISEASES

Abstract

Bioprinting technology has emerged as a transformative frontier in medical science, enabling the creation of complex, functional biological structures for applications in tissue engineering and disease management. This review article explores the evolution of bioprinting from its conventional three-dimensional (3D) constructs to the more sophisticated and biologically dynamic six-dimensional (6D) systems. The initial 3D approaches enabled the layer-by-layer deposition of cells and biomaterials, allowing the fabrication of anatomically relevant structures. However, their static nature and limited physiological functionality stimulated the development of four-dimensional (4D) bioprinting, which integrates time as a functional variable. Subsequent progress led to the development of five-dimensional (5D) bioprinting, which incorporates additional axes of complexity by enabling gradient material deposition and improved mechanical anisotropy. Besides, the most recent advancement, 6D bioprinting, introduces real-time adaptability, biological responsiveness, and multiscale integration. The review not only elucidated the applications but also shed light on the synergistic role of nanotechnology in cellular signaling, and tissue vascularization. The major applications include tissue regeneration, skin and cartilage repair, cancer modelling, neurodegenerative disease studies, and personalized organ fabrication. Despite advancements there are critical challenges such as limited vascular integration, mechanical fragility and ethical concerns which need to be addressed. The integration of artificial intelligence, in situ printing, and smart biomaterials is expected to drive the next phase of bioprinting innovation. This quantum leap from 3D to 6D printing not only enhances the precision of tissue engineering but also offers transformative potential for disease management and the future of precision medicine.